ISSN: 1522-4821

Journal international sur la santé mentale d'urgence et la résilience humaine

Accès libre

Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

Hepatitis C Infection among Intravenous Drug Users. “A Silent Disease in an Invisible Population”

Khalid Saaran, Hamad Al-Ghaferi, Abuelgasim El-Rasheed, Asma Awadhi and Ahmed Yousif Ali

Objective: Hepatitis is defined as an inflammation of the liver. Our objective is to highlight the devastating effects Hepatitis C, a subtype of viral hepatitis, has on a subpopulation of patients struggling with Alcohol use disorder (AUD) and SUDs (Substance Use Disorders) and specially IDUs, (Intravenous Drug Users) also known as the invisible population. We also aim to describe the clinical picture, viral genotypes and available treatments. Methods: A literature review was conducted, specifically looking at published materials about the objectives above. Conclusion: Hepatitis C is considered a global health problem. Described as a “silent disease” its complications include liver cirrhosis, end-stage liver disease and hepatocellular carcinoma, co-infection with HIV and super infections with different strains of HCV. Recent advances in understanding HCV virology have led to the development of new drugs targeting replication process and proving to be very successful in clearing the infection it is important to note that there is no vaccine yet for HCV infection.